ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) changes shares on Tuesday trading session, with a change of 2.52% or $0.04 shares. The trading starts at $1.59 and closed at $1.59 throughout the day. The trading session low price was $1.5311 and day high was $1.68 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 65989.0 while its average volume is 120.66K. In other hand, the ASLN market cap reached to $61.93M.
On May 11, 2020, BRIEF-Aslan Pharmaceuticals Reports First Quarter 2020 Financial Results. According to the news reported on Reuters, * ASLAN PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -4.12% and down -14.21% for month. Its quarterly performance was 1.87% above, while its half year performance is down -24.88%. ASLN yearly performance stood at negative -47.44% and fall -19.70% for year-to-date. Current recommendation for ASLAN Pharmaceuticals Limited is 2.30.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. ASLN EPS (TTM) for 12-month is -1.24. EPS for this year is 72.40%, while for the next year its value is -0.50.
Let’s take a look on the analyst recommendations on ASLN for the current month and previous month. For the current month, 2 of 3 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 4 analysts participate in stock recommendation. Out of 4, 0 rated it sell, 2 rated it as Buy and 2 as Hold Ratings. On the other hand, target price ranges from $5.00 – $6.00. Average target price for ASLN was reached at $5.50.
Temasek Holdings (Private) Limited, Sio Capital Management, LLC and Platinum Investment Management Ltd are the top three holders in ASLAN Pharmaceuticals Limited (ASLN) stock. On Mar 30, 2020, Temasek Holdings (Private) Limited has 1.42 million shares which valued 1.45 million. On Mar 30, 2020, Sio Capital Management, LLC owned 1.29 million shares which valued at 1.32 million. On Mar 30, 2020, Platinum Investment Management Ltd has a total of 0.42 million shares which valued at 0.42 million. In the end, Platinum Investment Management Ltd have 5.54% shares outstanding of ASLAN Pharmaceuticals Limited (ASLN) on Mar 30, 2020. The institutional holding shifted to 8.68%.
The company posted an EPS (TTM) of -1.24. According to the most recent quarter report on (Sep 2020), 3 analysts estimated an average EPS of -0.07, while -0.15 EPS posted a year ago period. Analyst Estimated EPS for ASLN published in the report was -$0.1 – -$0.02 during the same period. Comparing with last year, the average estimated EPS was -0.15 which is lower than -0.1 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for ASLN fall -9.74% for period of 200 days. SMA for 50 days was -11.91% which is showing red signal, while SMA-20 was -8.79%. The moving average value for ASLAN Pharmaceuticals Limited (ASLN) is 45.71k and 0.04% for 200 and 50 days respectively.